Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Child and Adolescent Psychopharmacology|October 31, 2006
Atomoxetine for attention-deficit/hyperactivity disorder symptoms in children with pervasive developmental disorders: a pilot studyPieter W Troost, Mark-Peter Steenhuis, Hanneke G Tuynman-Qua, et al.Pediatric Research|April 10, 2015
Why do children decide not to participate in clinical research: a quantitative and qualitative studyIrma M Hein, Pieter W Troost, Martine C de Vries, et al.Journal of Clinical Psychopharmacology|January 17, 2007
Prolactin release in children treated with risperidone: impact and role of CYP2D6 metabolismPieter W Troost, Bertine E Lahuis, Mirjam H Hermans, et al.Journal of Neuroimmunology|September 11, 2003
Increased seroreactivity in tic disorder patients to a 60 kDa protein band from a neuronal cell linePieter J Hoekstra, Gerda Horst, Pieter C Limburg, et al.Journal of the American Academy of Child and Adolescent Psychiatry|October 22, 2005
Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation studyPieter W Troost, Bertine E Lahuis, Mark-Peter Steenhuis, et al.Journal of Child and Adolescent Psychopharmacology|December 29, 2010
Risperidone-induced weight gain in referred children with autism spectrum disorders is associated with a common polymorphism in the 5-hydroxytryptamine 2C receptor genePieter J Hoekstra, Pieter W Troost, Bertine E Lahuis, et al.European Child & Adolescent Psychiatry|February 14, 2020
Prescribing antipsychotics in child and adolescent psychiatry: guideline adherenceMariken Dinnissen, Andrea Dietrich, Judith H van der Molen, et al.Journal of Clinical Psychopharmacology|December 21, 2020
Guideline Adherence of Monitoring Antipsychotic Use for Nonpsychotic Indications in Children and Adolescents: A Patient Record ReviewMariken Dinnissen, Andrea Dietrich, Judith H van der Molen, et al.Journal of Child and Adolescent Psychopharmacology|April 26, 2024
Long-Term Effectiveness of Off-Label Risperidone Treatment in Children and Adolescents: A Randomized, Placebo-Controlled Discontinuation StudyMariken Dinnissen, Andrea Dietrich, Margreet Bierens, et al.Pageof 2